Sarkar Chitra, Sharma Mehar Chand, Deb Prabal, Singh Rajbir, Santosh Vani, Shankar S K
Department of Pathology, All India Institute of Medical Sciences, New Delhi, Bangalore, India.
J Neurooncol. 2005 Jan;71(2):199-204. doi: 10.1007/s11060-004-1385-z.
Over the last two decades, an increase in the incidence of PCNSL cases has been reported in the West, both among immunosuppressed and immunocompetent patients. The present study was undertaken to assess the trend of incidence of PCNSL cases in India. To the best of our knowledge, only a single such report is available from India. All biopsy proven PCNSL cases obtained from the Neurosurgical databases of two large referral hospitals, one in Northern India (AIIMS, New Delhi) and another in Southern India (NIMHANS, Bangalore) from the period 1980 to 2003, were reviewed. Immunophenotyping was done and relevant clinical details collected. Appropriate statistical analysis was done to assess any change in trend of incidence or age at presentation. PCNSL cases constituted 0.95% and 0.92% of the total intracranial neoplasms at AIIMS and at NIMHANS, respectively. The mean age for cases diagnosed at AIIMS was 44.35 years, while that for NIMHANS was 39.51 years. Statistical analysis to evaluate any change in trend either of incidence or of age at presentation, over the study period, did not reveal any significant change. All the cases occurred in immunocompetent patients, except one case of HIV positive at NIMHANS, and one case of renal transplant at AIIMS. Frontal lobe was the most common site of involvement. Majority of the cases were diffuse, high grade, large cell lymphoma, B-cell immunophenotype. Thus, this multicentric hospital based study did not reveal any increase in incidence of PCNSL cases in India over the past 24 years. Further, in contrast to the West, majority of the cases in this Indian study were immunocompetent and a decade younger than in the West. The association of PCNSL with HIV/AIDS has been low in India, possibly due to early death in AIDS on account of opportunistic infections.
在过去二十年中,西方报道免疫抑制和免疫功能正常患者中原发性中枢神经系统淋巴瘤(PCNSL)病例的发病率均有所上升。本研究旨在评估印度PCNSL病例的发病率趋势。据我们所知,印度仅有一份此类报告。回顾了1980年至2003年期间从印度北部一家大型转诊医院(新德里全印医学科学研究所,AIIMS)和印度南部另一家医院(班加罗尔国家精神卫生和神经科学研究所,NIMHANS)的神经外科数据库中获取的所有经活检证实的PCNSL病例。进行了免疫表型分析并收集了相关临床细节。进行了适当的统计分析,以评估发病率趋势或发病年龄的任何变化。PCNSL病例分别占AIIMS和NIMHANS颅内肿瘤总数的0.95%和0.92%。在AIIMS诊断的病例平均年龄为44.35岁,而在NIMHANS为39.51岁。评估研究期间发病率或发病年龄趋势的任何变化的统计分析未发现任何显著变化。除了NIMHANS的一例HIV阳性病例和AIIMS的一例肾移植病例外,所有病例均发生在免疫功能正常的患者中。额叶是最常见的受累部位。大多数病例为弥漫性、高级别、大细胞淋巴瘤,B细胞免疫表型。因此,这项基于多中心医院的研究未发现过去24年印度PCNSL病例发病率有任何增加。此外,与西方不同,这项印度研究中的大多数病例免疫功能正常,且比西方病例年轻十岁。在印度,PCNSL与HIV/AIDS的关联较低,这可能是由于艾滋病患者因机会性感染过早死亡所致。